Age Labs, BioAge to Mine Norwegian Biobank Cohort to Produce New Diagnostics, Drugs. The partnership will see the two companies scour a Norwegian biobank for data that could produce a multitude of new aging-related tests, therapies, and perhaps... https://t.co/SQdA7GgN97
We've partnered with @bioagelabs on using longitudinal multi-omics data to investigate aging and age related diseases. The goal is to discover new drug targets and biomarkers for early disease detection. Read more at https://t.co/m24yq9Tgdr and https://t.co/MBYWzqfA1C
Each month we gather to hear from three #startups working to address infectious disease threats.
Join us TOMORROW at 1 p.m. as the teams from @age_labs, @Highnote_Health, and Peregrine Biosense share their latest updates. Email [email protected].
We're hiring. We are looking for a dedicated and independent bioinformatician to strengthen our team, to discover new biomarkers that will form the basis of next generation diagnostics for age-related diseases. https://t.co/2Ikd9fH4YF
Today I'm speaking at #Helseteknologikonferansen on how we at @Age_Labs combine data from biobanks and health registers to develop diagnostics for the early detection of age-related diseases and COVID-19. Program at https://t.co/pPoVWLpxqL
There is a growing number of Norwegian health startups and @Finansavisen has written about it in today's edition. I've snipped out the part about Age Labs.
The number of clinical trials in Norway is decreasing. Students from @CambridgeJBS together with @OsloCancer have looked into the problem and written a pretty cool report on the issue https://t.co/PJwdRT5xQa
This week we've been fundraising in and around San Francisco. We've met with angel investors, biohackers and others. We've really enjoyed ourselves. We had to stop by @innorhouse in Palo Alto to get some advice.
Today we presented our biomarker for aging, and how it can be used to improve patient selection, at Partnership for Life #p4l#oslolifescience@legemiddelind@snowpong @OsloCancer